Status:
COMPLETED
Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm]
Lead Sponsor:
Ipsen
Conditions:
Cervical Dystonia
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to investigate the efficacy of Dysport® in the treatment of cervical dystonia (CD) in a non-interventional long-term study in naïve and pre-treated patients.
Eligibility Criteria
Inclusion
- Suffering from cervical dystonia with rotational torticollis/-caput or laterocollis/-caput as the primary component
- Naïve to botulinum toxin A or pre-treated with botulinum toxin A on a regular basis for at least 2 years prior to inclusion and last injection with Dysport® and last injection between 3 and 6 months prior to inclusion
- With the intention to be treated with Dysport®
Exclusion
- The subject has already been included in this study
- Participation in an interventional trial
- Suffering from anterocollis or retrocollis as primary component
Key Trial Info
Start Date :
July 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
372 Patients enrolled
Trial Details
Trial ID
NCT01840462
Start Date
July 1 2012
End Date
March 1 2016
Last Update
January 14 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Graz, Austria
2
Wiesbaden, Germany